Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

dechra regulatory b.v. - phenobarbitalum inn - tafla - 25 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris aps - clidinii bromidum inn; chlordiazepoxidum inn - húðuð tafla

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - mesnum inn - stungulyf, lausn - 100 mg/ml

Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - crisantaspase - forvarnarfrumuæxli-eitilfrumuhvítblæði - Æxlishemjandi lyf - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

n.v. organon* - ezetimibum inn - tafla - 10 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - ezetimibum inn - tafla - 10 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - acitretinum inn - hart hylki - 25 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - acitretinum inn - hart hylki - 10 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - ezetimibum inn - tafla - 10 mg

Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

pfizer limited - celecoxib - adenomatous polyposis coli - Æxlishemjandi lyf - onsenal er ætlað til þess að fækka fjölda adenomatous þarmapólfa í fjölskyldufrumuæxli (fap) sem viðbót við skurðaðgerð og frekari eftirlitsskoðun (sjá kafla 4. Áhrif onsenal völdum lækkun g byrði á hættu á þarma krabbamein hefur ekki verið sýnt fram á (sjá kafla 4. 4 og 5.